Lupus patient decisions about clinical trial participation: a qualitative evaluation of perceptions, facilitators and barriers
Open accessThe DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Abstract
Objective: Although SLE disproportionately affects minority racial groups, they are significantly under-represented in clinical trials in the USA. This may lead to misleading conclusions in race-based subgroup analyses. We conducted focus groups to evaluate the perceptions of diverse patients with lupus about clinical trial participation. Methods: A qualitative research design employed three 90 min focus groups led by a trained moderator and guided by the Theory of Planned Behaviour. Open-ended questions about trial participation included advantages and disadvantages (behavioural beliefs), approving and disapproving significant others (normative beliefs), and participation enhancers and barriers (control beliefs). Discussions were recorded, transcribed and analysed to identify emerging themes. Results: Patients with SLE (n=23) aged 21–72, with increased proportion of minority groups (65%), participated. Reported advantages of trial participation included altruism and personal benefit. Disadvantages included uncertainties, disappointment, information burden, and life–health balance. Although some patients had discussed research participation with approving or disapproving family or friends, self-approval superseded external approval. Barriers included logistics and time, and facilitators included flexibility in scheduling, advance notice of studies, streamlined forms, and hope for SLE improvement. Conclusions: Knowledge about potential benefits of clinical trial participation was high. Minority patients demonstrated confidence in making their own informed decisions, but major barriers for all participants included burdensome forms, travel, childcare, and work. These suggest a major impact on minority and all recruitment from behavioural and control aspects, which should be considered in the logistics of trial design. This does not minimise the potential importance of improved access and education about clinical research.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The topic of patients withdrawing from clinical trials was scarcely discussed in the reviewed papers; only 4 studies explored this issue in African American and migrant groups [16, 34, 40, 46].”
From Enablers and barriers of clinical trial participation in adult patients from minority ethnic groups: a systematic review (2025) · cites this paper as [34]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Overall, participants were inspired by altruism [12, 33, 63] and a sense of helping others with a similar disease or to benefit future generations [34, 56].”
From Enablers and barriers of clinical trial participation in adult patients from minority ethnic groups: a systematic review (2025) · cites this paper as [34]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The theory of planned behavior
Ajzen, I. (1991) · Organizational Behavior and Human Decision Processes · doi:10.1016/0749-5978(91)90020-t · Cited by 90,587
Hochberg, M. C. (1997) · Arthritis & Rheumatism · doi:10.1002/art.1780400928 · Cited by 11,409
Petri, M., Orbai, A., Alarcón, G. S., Gordon, C., Merrill, J. T., Fortin, P. R., Bruce, I. N., Isenberg, D., Wallace, D. J., Nived, O., et al. (2012) · Arthritis & Rheumatism · doi:10.1002/art.34473 · Cited by 5,322
Self-citationFurie, R., Petri, M., Zamani, O., Cervera, R., Wallace, D. J., Tegzová, D., Sanchez-Guerrero, J., Schwarting, A., Merrill, J. T., Chatham, W. W., et al. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30613 · Cited by 1,683
Self-citationMycophenolate Mofetil versus Cyclophosphamide for Induction Treatment of Lupus Nephritis
Appel, G. B., Contreras, G., Dooley, M. A., Ginzler, E. M., Isenberg, D., Jayne, D., Li, L.-S., Mysler, E., Sa[Combining Acute Accent]nchez-Guerrero, J., Solomons, N., et al. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008101028 · Cited by 1,118
Corbie-Smith, G., Thomas, S. B., & St. George, D. M. M. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.21.2458 · Cited by 1,072
Attitudes and beliefs of african americans toward participation in medical research
Corbie-Smith, G., Thomas, S. B., Williams, M. V., & Moody-Ayers, S. (1999) · Journal of General Internal Medicine · doi:10.1046/j.1525-1497.1999.07048.x · Cited by 1,021
Wallace, D. J., Stohl, W., Furie, R. A., Lisse, J. R., McKay, J. D., Merrill, J. T., Petri, M. A., Ginzler, E. M., Chatham, W. W., McCune, W. J., et al. (2009) · Arthritis Care & Research · doi:10.1002/art.24699 · Cited by 585
Self-citationSomers, E. C., Marder, W., Cagnoli, P., Lewis, E. E., DeGuire, P., Gordon, C., Helmick, C. G., Wang, L., Wing, J. J., Dhar, J. P., et al. (2014) · Arthritis & Rheumatology · doi:10.1002/art.38238 · Cited by 449
Bastian, H. M., Roseman, J. M., Mcgwin, G., Alarcón, G. S., Friedman, A. W., Fessler, B. J., Baethge, B. A., Reveille, J. D., & Lumina Study Group (2002) · Lupus · doi:10.1191/0961203302lu158oa · Cited by 360
Cited by
Buie, J. N. J., McMillan, E., Kirby, J., Cardenas, L. A., Eftekhari, S., Feldman, C. H., Gawuga, C., Knight, A., Lim, S. S., McCalla, S., et al. (2023) · ACR Open Rheumatology · doi:10.1002/acr2.11590 · Cited by 65
Patient-centred clinical trial design
Tong, A., Scholes-Robertson, N. J., Hawley, C. M., Viecelli, A. K., Carter, S. A., Levin, A., Hemmelgarn, B. R., Harris, T., & Craig, J. C. (2022) · Nature Reviews Nephrology · doi:10.1038/s41581-022-00585-w · Cited by 58
Alarcón Garavito, G. A., Gilchrist, K., Ciurtin, C., Khanna, S., Chambers, P., McNally, N., Merivale, E., Carr, E., Yu, R., & Vindrola-Padros, C. (2025) · Trials · doi:10.1186/s13063-025-08769-y · Cited by 42
“The reasons driving people from minority ethnic groups who agreed to and continued to participate in clinical trials were discussed in 12 articles [10, 12, 33, 34, 43, 45, 48, 50, 56, 57, 63, 69].”
InfluentialBehavioural approaches to recruitment and retention in clinical trials: a systematic mapping review
Coffey, T., Duncan, E., Morgan, H. M., Lawrie, L., & Gillies, K. (2022) · BMJ Open · doi:10.1136/bmjopen-2021-054854 · Cited by 40
Childcare as a social determinant of access to healthcare: a scoping review
McArthur, M., Tian, P., Kho, K. A., Bhavan, K., Balasubramanian, B. A., & Ganguly, A. (2024) · Frontiers in Public Health · doi:10.3389/fpubh.2024.1443992 · Cited by 22
Metadata
- Authors
- Arriens, C., Aberle, T., Carthen, F., Kamp, S., Thanou, A., Chakravarty, E., James, J. A., Merrill, J. T., & Ogunsanya, M. E.
- Affiliations
- Oklahoma Medical Research Foundation (US)
- University of Oklahoma Health Sciences Center (US)
- Corresponding author
- Arriens, Cristina
- Venue
- Lupus Science & Medicine
- Publisher
- BMJ
- Published
- 2020-03
- Volume
- 7
- Issue
- 1
- Pages
- e000360
- ISSN
- 2053-8790 (ISSN-L)
- PMC
- PMC7073780
- OpenAlex
- W3011719344
- Semantic Scholar
- deabf173b102da59e32e85b32676250df40abc36
- Cited by
- 19
- References
- 37
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 2 · 2023: 7 · 2022: 4 · 2021: 2
- FWCI
- 2.43
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Lupus Science & Medicine (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- U.S. Department of Health and Human Services: Office of Minority Health (CPI-MP-17-002-1 2017 National Lupus Outreach)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Ethics in Clinical Research
- Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
- Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods in Clinical Trials
- Keywords
- systemic lupus erythematosus, clinical trial participation, patient decision-making, minority patients, underrepresentation in clinical trials, theory of planned behavior, barriers to clinical trial participation, informed consent, patient recruitment, altruism, family and friend influence
- MeSH terms
- Adult, Aged, Altruism, Clinical Trials as Topic, Culture, Decision Making, Female, Humans, Health Knowledge, Attitudes, Practice, Lupus Erythematosus, Systemic, Male, Middle Aged, Minority Groups, Oklahoma, Patient Participation, Perception, Focus Groups, Qualitative Research
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Lupus patient decisions about clinical trial participation: a qualitative evaluation of perceptions, facilitators and barriers. https://app.cochat.ai/papers/10.1136/lupus-2019-000360
- The paper
- Arriens, C., Aberle, T., Carthen, F., Kamp, S., Thanou, A., Chakravarty, E., James, J. A., Merrill, J. T., & Ogunsanya, M. E. (2020). Lupus patient decisions about clinical trial participation: a qualitative evaluation of perceptions, facilitators and barriers. Lupus Science & Medicine. https://doi.org/10.1136/lupus-2019-000360
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.